Mraz Amerine & Associates’s TORM TRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-6,585
Closed -$230K – 177
2024
Q1
$230K Sell
6,585
-500
-7% -$17K 0.04% 154
2023
Q4
$215K Sell
7,085
-3,419
-33% -$101K 0.05% 159
2023
Q3
$289K Sell
10,504
-150
-1% -$3.81K 0.07% 139
2023
Q2
$257K Sell
10,654
-200
-2% -$5.57K 0.06% 146
2023
Q1
$338K Hold
10,854
– – 0.08% 123
2022
Q4
$317K Hold
10,854
– – 0.07% 129
2022
Q3
$220K Hold
10,854
– – 0.06% 143
2022
Q2
$147K Buy
+10,854
New +$127K 0.04% 155

Other funds holding TRMD

Mraz Amerine & Associates's TRMD Position: Q2 2024 in Review

Mraz Amerine & Associates sold out of TORM (TRMD) in Q2 2024, closing a stake of 6,585 shares — an estimated $230K sold.

Mraz Amerine & Associates first reported a position in TRMD in Q2 2022 and held it in 8 quarters. The position peaked at $338K in Q1 2023. 143 funds tracked by Wall St. Rank hold TRMD as of Q2 2024.

  • Mraz Amerine & Associates reported no remaining TORM position as of Q2 2024 after selling out during the quarter.
  • Mraz Amerine & Associates sold 6,585 TORM shares in Q2 2024, an estimated $230K.
  • Mraz Amerine & Associates first reported a position in TORM in Q2 2022 and held it in 8 quarters.
  • Mraz Amerine & Associates's TORM position peaked at $338K in Q1 2023.
  • 143 funds tracked by Wall St. Rank held TORM as of Q2 2024.

Based on Mraz Amerine & Associates's 13F filing for Q2 2024, filed 1 Aug 2024.